WIP1, a Homeostatic Regulator of the DNA Damage Response, Is Targeted by HIPK2 for Phosphorylation and Degradation-Reference-Cited by-同舟云学术

WIP1, a Homeostatic Regulator of the DNA Damage Response, Is Targeted by HIPK2 for Phosphorylation and Degradation

Published:2013-08 Issue:3 Volume:51 Page:374-385
ISSN:1097-2765
Container-title:Molecular Cell
language:en
Short-container-title:Molecular Cell

Author:

Choi Dong Wook,Na Wooju,Kabir Mohammad Humayun,Yi Eunbi,Kwon Seonjeong,Yeom Jeonghun,Ahn Jang-Won,Choi Hee-Hyun,Lee Youngha,Seo Kyoung Wan,Shin Min Kyoo,Park Se-Ho,Yoo Hae Yong,Isono Kyo-ichi,Koseki Haruhiko,Kim Seong-Tae,Lee Cheolju,Kwon Yunhee Kim,Choi Cheol Yong

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference33 articles.

1. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway;Bulavin;Nat. Genet.,2004

2. HIPK2: a versatile switchboard regulating the transcription machinery and cell death;Calzado;Cell Cycle,2007

3. Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1;Choi;J. Biol. Chem.,2008

4. Homeodomain-interacting protein kinase-2 restrains cytosolic phospholipase A2-dependent prostaglandin E2 generation in human colorectal cancer cells;D’Orazi;Clin. Cancer Res.,2006

5. Updates on HIPK2: a resourceful oncosuppressor for clearing cancer;D’Orazi;J. Exp. Clin. Cancer Res.,2012

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crystal structure and mechanistic studies of the PPM1D serine/threonine phosphatase catalytic domain;Journal of Biological Chemistry;2024-08

2. HIPK3 maintains sensitivity to platinum drugs and prevents disease progression in gastric cancer;Cancer Letters;2024-03

3. WIP1 is a novel specific target for growth hormone action;iScience;2023-11

4. Wip1 contributes to the adaptation of HepG2 human liver cancer cells to stress hormone‑induced DNA damage;Oncology Letters;2022-11-29

5. DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities;Experimental & Molecular Medicine;2022-10-07